Using the E-Tcl1 CLL mouse model, Heinig et al. demonstrated that CXCR5 deletion lowers E-Tcl1 leukemogenesis and CLL proliferation. The gene discussed is CXCR5; the disease is B-cell chronic lymphocytic leukemia.